The Journal is Indexed in
3 - Effects of patient controlled axillary analgesia and continuous axillary infusion with 0.2% ropivacaine for postoperatif pain relief
Türkan Şanlıer, Leyla Türkoğlu Kılınç, Ayşe Hancı, Melahat Karatmanlı Erol, Banu Burgutoğlu
Objective: In our propective, randomized study, analgesic efficacy and safety of 24 h continuous axillary infusion or patient controlled axillary analgesia of 2 mg/ml ropivacaine for postoperative pain relief were investigated in patients undergoing hand and forearm surgery.
Study Design: P re operatively, all patients received an axillary brachial plexus block (0.75% ropivacaine, 40 ml) and perineural catheter. Postoperatively, patients were randomly assigned one of two groups: patient controlled axillary analgesia with 0.2% ropivacaine (bolus: 0.25 mg/kg, lockout period: 60 min) or continuous axillary infusion of 0.2% ropivacaine at 0.25 mglkglh. Postoperative pain at rest was assessed by visual analog scale. Supplementary analgesic consumption and side effects were recorded.
Results: Postoperative analgesia quality and analgesic consumption were similar in both groups. Total consumption of local anesthetic during 24 h was 72.71±38.95 mg in patient controlled axillary group and 386.40±106.85 mg in continuous axillary infusion group (j-><0.0001). The degree of motor block was deeper in continuous group. No sign or symptom of systemic local anesthetic toxicity was observed.
Coclusion: This study demonstrates that, patient controlled axillary analgesia of 0.25 mg/kg, 0.2% ropivacaine provides adequate pain relief and earlier recovery of motor function with less local anesthetic volume during 24 h after surgery.
Keywords: Brachial plexus block, ropivacaine, postoperative analgesia
To read full article click